Noteholder Notice: Zwerling, Schachter & Zwerling, LLP and Kohrman Jackson & Krantz, PLL Alert Purchasers of Medical Capital Notes of November 20, 2009 Deadline for Filing a Motion Seeking to be Appointed Lead Plaintiff

Noteholder Notice: Zwerling, Schachter & Zwerling, LLP and Kohrman Jackson &
Krantz, PLL Alert Purchasers of Medical Capital Notes of November 20, 2009
Deadline for Filing a Motion Seeking to be Appointed Lead Plaintiff

NEW YORK, Nov. 9 /PRNewswire/ -- On November 6, 2009, Zwerling, Schachter &
Zwerling, LLP ("Zwerling Schachter") and Kohrman Jackson & Krantz PLL
("Kohrman Jackson") filed a class action lawsuit in the United States District
Court for the Central District of California on behalf of all persons or
entities who purchased or otherwise acquired promissory notes issued by
Medical Capital Holdings, Inc.'s special purpose corporations ("SPCs"),
Medical Provider Financial Corporation III ("MP III"), Medical Provider
Financial Corporation IV ("MP IV"), Medical Provider Funding Corporation V
("MP V"), and/or Medical Provider Funding Corporation VI ("MP VI") (the
"Notes") on or after September 18, 2006 (the "Class Period"). The lawsuit
names Securities America, Inc., Ameriprise Financial, Inc. and Securities
America Financial Corporation as defendants.

The complaint alleges that defendants violated Sections 12(a)(1), 12(a)(2) and
15 of the Securities Act of 1933. Specifically, the complaint claims that
defendants failed to adequately perform due diligence in connection with the
sale of the Notes, and that defendants sold non-exempt securities that were
not registered with the Securities and Exchange Commission. Further, the
complaint alleges that the private placement memoranda for the Notes contained
false and materially misleading statements that misrepresented and failed to
disclose that: (a) collateral and other assets of the SPCs had values that
were inflated and/or unreliable; (b) accounting practices did not comply with
GAAP and financial records and valuations were unreliable; (c) there was a
lack of sufficient internal controls over the investments made by the SPCs;
(d) that investor funds raised through the sale of Notes in the Offerings
would be used to pay administrative fees; (e) funds received in connection
with an offering would be commingled with the funds received from other
offerings; and (f) the SPCs had defaulted in their obligations to Noteholders.

On July 16, 2009, the SEC commenced an enforcement action against Medical
Capital Holdings, Inc. and related entities and individuals for securities
violations alleging that the Medical Capital entities perpetrated a fraudulent
scheme. Also on July 16, 2009, the SEC sought, among other things, the
appointment of a receiver over these entities. Shortly thereafter a Receiver
was appointed.

If you purchased any Notes issued by MP III, IV, V and/or VI after September
18, 2006, you may apply to serve as lead plaintiff. The lead plaintiff is
responsible for overseeing the prosecution of the action and ensuring that the
interests of the class are protected. Should you desire to be lead plaintiff,
you may apply to be appointed through Zwerling Schachter and Kohrman Jackson,
as counsel. The lead plaintiff deadline is November 20, 2009.

If you wish to discuss this securities class action or have any questions
concerning your rights and interests with respect to this matter, please
contact Zwerling Schachter (Stephanie Kirwan, Esq.) at (800) 721-3900 or by
e-mail at skirwan@zsz.com; or Kohrman Jackson (Ari Jaffe, Esq.) at (216)
696-8700 or by e-mail at ahj@kjk.com.

Zwerling, Schachter & Zwerling, LLP concentrates in prosecuting class actions
nationwide on behalf of investors. The firm currently plays a leading role in
numerous major securities and complex commercial litigations pending in
federal and state courts and has offices in New York, Garden City, N.Y., and
Seattle. The firm has been recognized by courts throughout the country as
highly experienced and skilled in complex litigation, particularly with
respect to federal securities class action litigation.

Kohrman Jackson & Krantz PLL is a Cleveland-based law firm representing
individuals and companies throughout the United States. The firm concentrates
in sophisticated business transactions and complex litigation with areas of
practice including securities, commercial litigation, corporate and finance,
tax, real estate, and technology and intellectual property.

Visit our Web sites at: www.zsz.com and www.kjk.com.

SOURCE Zwerling, Schachter & Zwerling, LLP

Zwerling Schachter, Stephanie Kirwan, Esq., 1-800-721-3900, skirwan@zsz.com,
or Kohrman Jackson, Ari Jaffe, Esq., +1-216-696-8700, ahj@kjk.com